GlassScriptPhysician profile
Haibin Zhang
NPI 1386946481
$3,574.76
in general payments reported to CMS, 2019-2025
29 companies · $696 in 2025
The $696 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $1,267 · 2023: $694 · 2024: $699 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,088.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,088.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $604.71 | 2021-2025 | Myrbetriq, Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $564.26 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $354.49 | 2021-2024 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Urovant Sciences INC | $273.85 | 2021-2022 | |
| Pfizer INC. | $247.61 | 2023-2025 | |
| Janssen Biotech, INC. | $180.42 | 2022-2025 | Erleada |
| Antares Pharma, INC. | $131.11 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Myovant Sciences INC. | $126.50 | 2022 | |
| Progenics Pharmaceuticals, INC. | $114.70 | 2022-2024 | |
| Telix Pharmaceuticals | $109.60 | 2025 | Illuccix |
| Urogen Pharma, INC. | $108.58 | 2021-2025 | |
| Accord Healthcare, INC. | $91.01 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $84.00 | 2021-2022 | |
| Verity Pharmaceuticals INC. | $75.22 | 2023-2024 | Trelstar |
| Tolmar Pharmaceuticals, INC. | $59.44 | 2021-2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $57.41 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.05 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $51.05 | 2021-2023 | Prolaris |
| Palette Life Sciences, INC. | $49.55 | 2022 | |
| Coloplast Corp | $33.96 | 2022 | |
| 180 Medical, INC. | $33.78 | 2022-2025 | Gentlecath Glide |
| Novartis Pharmaceuticals Corporation | $30.65 | 2025 | |
| Immunitybio, INC. | $27.89 | 2025 | |
| Tempus Ai, INC | $26.67 | 2025 | Xt Cdx |
| Bioprotect Medical, INC. | $22.86 | 2024 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $20.69 | 2021 | |
| Amgen INC. | $15.12 | 2021 | |
| Olympus America INC. | $13.84 | 2025 | Itind System |
| Blue Earth Diagnostics | $12.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haibin Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.